A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells

British Journal of Pharmacology

Volumn 157, Issue 8, 2009, Pages 1451-1462

  Sztiller Sikorska, M ^a   Jakubowska, J ^a   Wozniak, M ^a   Stasiak, M ^a   Czyz, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Ara C; Caspase 3; Cisplatin; Differentiation; Doxorubicin; Haemin; Hydroxyurea; K562 cells

Indexed keywords

CASPASE 3; CISPLATIN; CYTARABINE; DOXORUBICIN; GLYCOPHORIN A; HEMIN; HEMOGLOBIN; HYDROXYUREA; TRANSCRIPTION FACTOR GATA 1;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CELL DIFFERENTIATION; CELL SURVIVAL; CISPLATIN; CYTARABINE; DOXORUBICIN; GATA1 TRANSCRIPTION FACTOR; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYDROXYUREA; K562 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70350347711     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00333.x     Document Type: Article

References (67)

1. Addya S, Keller MA, Delgrosso K, Ponte CM, Vadigepalli R, Gonye GE et al. (2004). Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements. Physiol Genomics 19: 117-130.
2. Aispuru GR, Aguirre MV, Aquino-Esperanza JA, Lettieri CN, Juaristi JA, Brandan NC (2008). Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3. Cell Biol Int 32: 966-978.
3. Baliga BS, Mankad M, Shah AK, Mankad VN (1993). Mechanism of differentiation of human erythroleukaemic cell line K562 by haemin. Cell Prolif 26: 519-529.
4. Belhacène N, Maulon L, Guérin S, Ricci JE, Mari B, Colin Y et al. (1998). Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin. FASEB J 12: 531-539.
5. Benito A, Silva M, Grillot D, Nuñez G, Fernández-Luna JL (1996). Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood 87: 3837-3843.
6. Bianchi N, Ongaro F, Chiarabelli C, Gualandi L, Mischiati C, Ber-gamini P et al. (2000). Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol 60: 31-40.
7. Carlile GW, Smith DH, Wiedmann M (2004). Caspase-3 has a non-apoptotic function in erythroid maturation. Blood 103: 4310-4316.
8. Chénais B (1998). Requirement of GATA-1 and p45 NF-E2 expression in butyric acid-induced erythroid differentiation. Biochem Biophys Res Commun 253: 883-886.
9. Cioe L, McNab A, Hubbell HR, Meo P, Curtis P, Rovera G (1981). Differential expression of the globin genes in human leukaemia K562(S) cells induced to differentiate by hemin or butyric acid. Cancer Res 41: 237-243.
10. Cortesi R, Gui V, Gambari R, Nastruzzi C (1999). In vitro effect on human leukemic K562 cells of co-administration of liposome-associated retinoids and cytosine arabinoside (Ara-C). Am J Hematol 62: 33-43.
11. Czyz M, Gniazdowski M (1998). Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site. Acta Biochim Pol 45: 67-73.
12. Czyz M, Szulawska A, Bednarek AK, Düchler M (2005). Effects of anthracycline derivatives on human leukemia K562 cell growth and differentiation. Biochem Pharmacol 70: 1431-1442.
13. Czyz M, Jakubowska J, Sztiller-Sikorska M (2008). STI571/doxorubicin concentration-dependent switch for diverse caspase actions in CML cell line K562. Biochem Pharmacol 75: 1761-1773.
14. Dean A, Erard F, Schneider AP, Schechter AN (1981). Induction of hemoglobin accumulation in human K562 cells by hemin is reversible. Science 212: 459-461.
15. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F et al. (1999). Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-493.
16. Di Pietro R, di Giacomo V, Caravatta L, Sancilio S, Rana RA, Cataldi A (2007). Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation. J Cell Biochem 100: 1070-1079.
17. Droin N, Cathelin S, Jacquel A, Guéry L, Garrido C, Fontenay M et al. (2008). A role for caspases in the differentiation of erythroid cells and macrophages. Biochimie 90: 416-422.
18. Faderl S, Ferrajoli A, Harris D, Van Q, Kantarjian H, Estrov Z (2007). Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cells. Leuk Res 31: 91-95.
19. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA (2002). Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99: 11025-11030.
20. Fernando P, Brunette S, Megeney LA (2005). Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J 19: 1671-1673.
21. Fu WN, Bertoni F, Kelsey SM, McElwaine SM, Cotter FE, Newland AC et al. (2003). Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene 22: 451-455.
22. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, Flavell RA et al. (2008). Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2: 595-601.
23. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM et al. (2008). No death without life: vital functions of apoptotic effectors. Cell Death Differ 15: 1113-1123.
24. Gewirtz DA (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741.
25. Gillet R, Bobichon H, Trentesaux C (2002). Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation. Biol Cell 94: 267-273.
26. Grebenová D, Kuzelová K, Pluskalová M, Peslová G, Halada P, Hrkal Z (2006). The proteomic study of sodium butyrate antiproliferative/ cytodifferentiation effects on K562 cells. Blood Cells Mol Dis 37: 210-217.
27. Gregoli PA, Bondurant MC (1997). The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90: 630-640.
28. Gregoli PA, Bondurant MC (1999). Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol 178: 133-143.
29. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ (1999). GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94: 87-96.
30. Guo F, Sigua C, Bali P, George P, Fiskus W, Scuto A et al. (2005). Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. Blood 105: 1246-1255.
31. Huang M, Wang Y, Collins M, Graves LM (2004). CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase. Leukemia 18: 1857-1863.
32. Iwasaki H, Huang P, Keating MJ, Plunkett W (1997). Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood 90: 270-278.
33. Jäättelä M, Wissing D, Kokholm K, Kallunki T, Egeblad M (1998). Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17: 6124-6134.
34. Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G et al. (2003). Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. FASEB J 17: 2160-2162.
35. Jacquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S et al. (2007). Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Oncogene 26: 2445-2458.
36. Jakubowska J, Wasowska-Lukawska M, Czyz M (2008). STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochon-drial pathway of apoptosis. Eur J Pharmacol 596: 41-49.
37. Jeannesson P, Lahlil R, Chenais B, Devy L, Gillet R, Aries A et al. (1997). Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression. Leuk Lymphoma 26: 575-587.
38. Jia L, Patwari Y, Srinivasula SM, Newland AC, Fernandes-Alnemri T, Alnemri ES et al. (2001). Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis. Oncogene 20: 4817-4826.
39. King SB (2003). The nitric oxide producing reactions of hydroxyurea. Curr Med Chem 10: 437-452.
40. Kuranaga E, Miura M (2007). Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 17: 135-144.
41. Kurz EU, Wilson SE, Leader KB, Sampey BP, Allan WP, Yalowich JC et al. (2001). The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hyper-sensitivity to etoposide in human leukemic cell lines. Mol Cancer Ther 1: 121-131.
42. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P (2007). Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14: 44-55.
43. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C (2005). Vital functions for lethal caspases. Oncogene 24: 5137-5148.
44. Miura M, Chen XD, Allen MR, Bi Y, Gronthos S, Seo BM et al. (2004). A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 114: 1704-1713.
45. Moll T, Czyz M, Holzmüller H, Hofer-Warbinek R, Wagner E, Winkler H et al. (1995). Regulation of the tissue factor promoter in endot-helial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem 270: 3849-3857.
46. Moosavi MA, Yazdanparast R, Lotfi A (2007). ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5′-triphosphate- mediated terminal erythroid differentiation of K562 cells. Int J Biochem Cell Biol 39: 1685-1697.
47. Morceau F, Aries A, Lahlil R, Devy L, Jardillier JC, Jeannesson P et al. (1996). Evidence for distinct regulation processes in the aclacinomycin-and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochem Pharmacol 51: 839-845.
48. Nakamichi I, Habtezion A, Zhong B, Contag CH, Butcher EC, Omary MB (2005). Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction. J Clin Invest 115: 3007-3014.
49. Oetzel C, Jonuleit T, Götz A, van der Kuip H, Michels H, Duyster J et al. (2000). The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X. Clin Cancer Res 6: 1958-1968.
50. Okuyama R, Nguyen BC, Talora C, Ogawa E, Tommasi di Vignano A, Lioumi M et al. (2004). High commitment of embryonic kerati-nocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. Dev Cell 6: 551-562.
51. Park JI, Choi HS, Jeong JS, Han JY, Kim IH (2001). Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ 12: 481-486.
52. Partington GA, Patient RK (1999). Phosphorylation of GATA-1 increases its DNA-binding affinity and is correlated with induction of human K562 erythroleukaemia cells. Nucleic Acids Res 27: 1168-1175.
53. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V et al. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349: 257-260.
54. Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, Dussiot M et al. (2007). Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 445: 102-105.
55. Rodrigue CM, Arous N, Bachir D, Smith-Ravin J, Romeo PH, Galacteros F et al. (2001). Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol 113: 500-507.
56. Schwerk C, Schulze-Osthoff K (2003). Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 66: 1453-1458.
57. Siddik ZH (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
58. Sordet O, Rébé C, Plenchette S, Zermati Y, Hermine O, Vainchenker W et al. (2002). Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100: 4446-4453.
59. Szulawska A, Gniazdowski M, Czyz M (2005). Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA. Biochem Pharmacol 69: 7-18.
60. Szulawska A, Arkusinska J, Czyz M (2007). Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives. Biochem Pharmacol 73: 175-184.
61. Weber GF, Menko AS (2005). The canonical intrinsic mitochondrial death pathway has a non-apoptotic role in signaling lens cell differentiation. J Biol Chem 280: 22135-22145.
62. Weiss MJ, Orkin SH (1995). Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA 92: 9623-9627.
63. Witt O, Sand K, Pekrun A (2000). Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95: 2391-2396.
64. Woessmann W, Mivechi NF (2001). Role of ERK activation in growth and erythroid differentiation of K562 cells. Exp Cell Res 264: 193-200.
65. Woessmann W, Zwanzger D, Borkhardt A (2004). ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent. Cell Biol Int 28: 403-410.
66. Zandy AJ, Lakhani S, Zheng T, Flavell RA, Bassnett S (2005). Role of the executioner caspases during lens development. J Biol Chem 280: 30263-30272.
67. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. (2001). Caspase activation is required for terminal erythroid differentiation. J Exp Med 193: 247-254.